|Articles|January 27, 2020
Modulating IgG effector function by FC engineering and glycoengineering PDF
This paper summarizes approaches for modulating antibody effector functions and pharmacokinetics, and provides examples of antibodies in clinical studies employing such approaches.
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
In-Vivo Cell Therapy Model Aims to Reduce Manufacturing Challenges
2
Streamlining Procurement and Inventory Management Leads to Increased Productivity
3
A Strategic Assessment Tool for Modernizing Buffer Preparation in Biologics Facilities
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
